What is the Incidence of Barrett's and Gastric Metaplasia in Esophageal Atresia/Tracheoesophageal Fistula (EA/TEF) Patients?

Abstract

Objective: Aim of the study was to document the incidence of gastric and intestinal metaplasia (Barrett's esophagus) in a closely followed group with EA/TEF, determine the efficacy of pH probe studies in diagnosing reflux and, moreover, to determine the lag period between the development of gastroesophageal reflux disease (GERD) and metaplasia.

Materials and Methods: Patients who underwent EA/TEF correction were followed up over an 18-year period (1990–2009) with regular pH probe and endoscopy investigations. Biopsies were performed at 3 year intervals to evaluate for metaplastic changes in the esophageal epithelium. The interval between esophageal atresia correction and the development of erosive esophagitis, gastric metaplasia and Barrett's esophagus was determined. The development of complicated GERD was statistically correlated to age at detection.

Results: 51 patients (28 male) underwent EA/TEF correction during the study period. The ages of the children followed up ranged from 7 months to 19 years. There were 5 Type A, 44 Type C and 2 Type D fistulas. 37 patients (5 Type A, 31 Type C, 1 Type D) had documented reflux and 14 did not. 17 (46%) of the patients with reflux underwent an anti-reflux operation. 4 of the 17 underwent 2 or more anti-reflux procedures. 21 patients had pH probe studies positive for reflux, 3 had negative pH probe studies after an anti-reflux operation. 18 of the 37 patients with reflux (about 50%) needed esophageal dilatation for either anastamotic or non-anastamotic strictures. Only 4/14 (28.5%) patients without reflux underwent dilatations and only in their first year of life (p=NS). 15 patients had mucosal abnormalities in endoscopic biopsies. 8 patients had gastric metaplasia and 1 patient had Barrett's esophagus. The mean age in the group with metaplasia (gastric and intestinal) was 13 years, which was significantly different from the mean age of the group (5.2 years) without mucosal changes (p<0.001). 2 patients with normal pH probe studies had metaplasia on biopsies.

Conclusion: Metaplasia arises in about 15% of patients with EA/TEF. The lag time to developing metaplasia from the time of initial surgical correction is about 10 years. Endoscopy and biopsies are the best way of detecting mucosal changes.

Key words

esophageal atresia - Barrett's esophagus - metaplasia - screening

References

• 1 Pultrum BB, Bijleved CM, de Langen ZJ. et al . Development of an adenocarcinoma of the esophagus 22 years after primary repair of a congenital atresia.  J Pediatr Surg. 2005;  40 E1-E4
• 2 Sistonen SJ, Koivusalo A, Lindahl H. et al . Cancer after repair of esophageal atresia population-based long-term follow-up.  J Pediatr Surg. 2008;  43 602-605
• 3 Beddow ECL, Wilcox DT, Drake DP. et al . Surveillance of Barrett's esophagus in children.  J Pediatr Surg. 1999;  34 (1) 88-91
• 4 Cheu HW, Grosfeld JL, Heifetz SA. et al . Persistance of Barrett's esophagus in children after antireflux surgery: Influence of follow-up care.  J Pediatr Surg. 1992;  27 (2) 260-266
• 5 Johnson DG, Beasley SW. Gastro-esophageal reflux. In: Beasley SW, Myers NA, and, Auldist AW, eds. Esophageal Atresia. London: Chapman & Hall Medical; 1991: 341-358
• 6 Kovesi T. Long term complications of congenital esophageal atresia and/or tracheoesophageal fistula.  Chest. 2004;  126 915-925
• 7 Eposito C. Laparoscopic antireflux procedures in the management of gastroesophageal reflux following esophageal atresia repair.  J Pediatr Gastroenterol Nutr. 2005;  40 349-351
• 8 Krug E, Bergmeijer JH, Dees J. et al . Gastroesophageal reflux and Barret's esophagus in adults born with esophageal atresia.  Am J Gastroenterol. 1999;  94 (10) 2825-2828
• 9 Little DC, Rescorla FJ, Grosfeld JL. et al . Long term analysis of children with esophageal atresia and tracheoesophageal fistula.  J Pediatr Surg. 2003;  38 852-856
• 10 Duerloo JA, Ekkelkamp S, Schoorl M. et al . Esophageal atresia: historical evolution of management and results in 371 patients.  Ann Thorac Surg. 2002;  73 267-272
• 11 Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population.  Gut. 1998;  42 690-695
• 12 Fan X, Snyder N. Prevalence of Barrett's esophagus in patients with or without GERD symptoms: role of race, age, and gender.  Dig Dis Sci. 2008;  54 (3) 572-577
• 13 Falk GW. Unresolved issues in Barrett's esophagus in the new millennium.  Dig Dis. 2000;  18 27-42
• 14 Deurloo JA, Ekkelkamp S, Taminiau J. et al . Esophagitis and Barrett esophagus after correction of esophageal atresia.  J Pediatr Surg. 2005;  40 1227-1231
• 15 Masclee AA, de Best AC, de Graaf R. et al . Ambulatory 24-h pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy.  Scand J Gastroenterol. 1990;  25 (3) 225-230
• 16 Bergmeijer JLJ, Hazebroek FWJ. Prospective medical and surgical treatment of gastroesophageal reflux in esophageal atresia.  JACS. 1998;  187 (2) 153-157
• 17 Mc Donald ML, Trastek VF, Allen MS. et al . Barrett's esophagus: Does an antireflux procedure reduce the need for endoscopic surveillance?.  J of Thoracic and Cardiovasc Surg. 1996;  111 (6) 1135-1140
• 18 Falk GW. Current challenges in Barrett's esophagus.  Cleveland Clinic Journal of Medicine. 2001;  68 (5) 415-420

Correspondence